首页 › 基金 › Affinity Asset Advisors, LLC › CLYM
Affinity Asset Advisors, LLC 对 CLYM 的持仓历史
CLIMB BIO INC · 医疗保健
Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 CLYM(CLIMB BIO INC)972,000 股,市值约 US$11.1M,约占其申报组合的 0.52%,在其申报持仓中市值排名第 43 位。 Affinity Asset Advisors, LLC 最近 10 个申报季度中有 10 个季度披露了 CLYM 持仓,最早可追溯至 Q2 2024。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Affinity Asset Advisors, LLC 对 CLYM 的持仓演变
Affinity Asset Advisors, LLC 于 Q2 2024 首次披露 CLYM 持仓:1,670,661 股(约 US$11.9M)。 该持仓在 Q2 2026 达到峰值 972,000 股,市值约 US$12.7M。 在 10 次申报中,Affinity Asset Advisors, LLC 2 次增持、4 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 972,000 股、市值约 US$11.1M。 持仓曾出现大幅变动:Q4 2024 减持约 67% (随后一个季度股价下跌 32%)、Q1 2025 增持约 200% (随后一个季度股价上涨 2%)、Q1 2026 减持约 46% (随后一个季度股价上涨 90%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2024 | 1.67M | $11.88M | 新进 |
| Q3 2024 | 1.50M | $7.63M | 减持 |
| Q4 2024 | 500.00K | $900.00K | 减持 |
| Q1 2025 | 1.50M | $1.83M | 增持 |
| Q2 2025 | 1.50M | $1.86M | 持有 |
| Q3 2025 | 1.30M | $2.61M | 减持 |
| Q4 2025 | 1.30M | $5.20M | 持有 |
| Q1 2026 | 700.00K | $4.79M | 减持 |
| Q2 2026 | 972.00K | $12.67M | 增持 |
| Q3 2026 | 972.00K | $11.15M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CLYM 与 13F 数据
CLYM(CLIMB BIO INC)属于医疗保健行业。我们追踪的基金中还有 72 只申报持有 CLYM,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CLYM 的基金
- RA CAPITAL MANAGEMENT, L.P. 11.30M 股 · $147.36M · Q2 2026
- BRAIDWELL LP 2.80M 股 · $36.48M · Q2 2026
- Cormorant Asset Management, LP 2.11M 股 · $27.46M · Q2 2026
- Redmile Group, LLC 1.23M 股 · $15.99M · Q2 2026
- GREAT POINT PARTNERS LLC 1.00M 股 · $13.04M · Q2 2026
- ADAR1 Capital Management, LLC 822.65K 股 · $10.73M · Q2 2026
- STEMPOINT CAPITAL LP 742.75K 股 · $9.69M · Q2 2026
- Parkman Healthcare Partners LLC 563.48K 股 · $7.35M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 521.08K 股 · $6.79M · Q2 2026
- SPHERA FUNDS MANAGEMENT LTD. 483.75K 股 · $6.31M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K 股 · $4.14M · Q3 2026
- Ally Bridge Group (NY) LLC 249.17K 股 · $3.25M · Q2 2026
更多关于 Affinity Asset Advisors, LLC
常见问题
How long has Affinity Asset Advisors, LLC held CLYM?
Affinity Asset Advisors, LLC has disclosed CLYM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Affinity Asset Advisors, LLC's current position in CLYM?
As of Q3 2026, Affinity Asset Advisors, LLC holds 972.00K shares of CLYM (CLIMB BIO INC), valued at $11.15M, representing 0.52% of its reported portfolio and ranking #43.
Has Affinity Asset Advisors, LLC been buying or selling CLYM?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in CLYM. The position peaked in Q2 2026 at 972.00K shares.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.